CareDx, Inc. (CDNA) vs GeneDx Holdings Corp. (WGS)
- CareDx, Inc. CDNA 63.81 −4.30%
- GeneDx Holdings Corp. WGS 63.60 −9.43%
CareDx, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $3.5B against $2.1B — 1.7× the size. GeneDx Holdings Corp. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 29.7×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against 25.4%. CareDx, Inc. has the higher net margin (24.2% vs −23.4%) and the higher return on invested capital (130.1% vs −27.7%). Across the 18 metrics below, CareDx, Inc. leads on 13 and GeneDx Holdings Corp. on 5.
Valuation
Profitability
| Metric | CDNA | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.58% | 69.37% | 50.89% |
| Operating margin | 23.61% | (20.34%) | (8.57%) |
| Net margin | 24.23% | (23.40%) | (6.37%) |
| Free cash flow margin | 18.49% | (16.68%) | 0.00% |
| Return on equity | 29.49% | (40.80%) | (2.92%) |
| Return on assets | 22.72% | (22.50%) | (6.71%) |
| Return on invested capital | 130.06% | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack